Medika d.d. (ZSE:MDKA)
Croatia
· Delayed Price · Currency is EUR 4,600.00
+40.00 (0.88%)
At close: Mar 4, 2026
Medika d.d. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 952.62 | 826.32 | 745.79 | 628.1 | 549.59 | Upgrade
|
| Other Revenue | - | 6.12 | 4.69 | - | - | Upgrade
|
| Revenue | 952.62 | 832.45 | 750.49 | 628.1 | 549.59 | Upgrade
|
| Revenue Growth (YoY) | 14.44% | 10.92% | 19.49% | 14.28% | 4.00% | Upgrade
|
| Cost of Revenue | 897.13 | 766.87 | 690.85 | 577.1 | 504.03 | Upgrade
|
| Gross Profit | 55.49 | 65.57 | 59.64 | 51 | 45.56 | Upgrade
|
| Selling, General & Admin | 18.72 | 26.21 | 22.93 | 20.62 | 19.18 | Upgrade
|
| Other Operating Expenses | 8.98 | 11.39 | 10.05 | 9.04 | 7.8 | Upgrade
|
| Operating Expenses | 33.81 | 42.38 | 37.31 | 33.69 | 30.87 | Upgrade
|
| Operating Income | 21.68 | 23.19 | 22.33 | 17.31 | 14.69 | Upgrade
|
| Interest Expense | -2.11 | -2 | -1.73 | -0.37 | -0.59 | Upgrade
|
| Interest & Investment Income | 13.66 | 3 | 2.28 | 2.65 | 1.4 | Upgrade
|
| Earnings From Equity Investments | 0.55 | 0.51 | 0.43 | 0.43 | 0.38 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.01 | -0.01 | -0.28 | 0.13 | Upgrade
|
| EBT Excluding Unusual Items | 33.79 | 24.69 | 23.3 | 19.74 | 16 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.14 | 1.08 | 0.9 | 0.08 | Upgrade
|
| Pretax Income | 33.79 | 24.83 | 24.37 | 20.64 | 16.08 | Upgrade
|
| Income Tax Expense | 6 | 4.52 | 4.29 | 5.15 | 2.84 | Upgrade
|
| Net Income | 27.78 | 20.31 | 20.08 | 15.5 | 13.24 | Upgrade
|
| Net Income to Common | 27.78 | 20.31 | 20.08 | 15.5 | 13.24 | Upgrade
|
| Net Income Growth | 36.80% | 1.15% | 29.59% | 17.03% | 30.03% | Upgrade
|
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | - | - | - | 2.56% | 3.59% | Upgrade
|
| EPS (Basic) | 959.62 | 701.49 | 693.51 | 535.16 | 468.99 | Upgrade
|
| EPS (Diluted) | 959.62 | 701.49 | 693.51 | 535.16 | 468.99 | Upgrade
|
| EPS Growth | 36.80% | 1.15% | 29.59% | 14.11% | 25.53% | Upgrade
|
| Free Cash Flow | 11.65 | -34.56 | 19.58 | 7.33 | 35.88 | Upgrade
|
| Free Cash Flow Per Share | 402.47 | -1193.44 | 676.38 | 253.26 | 1270.88 | Upgrade
|
| Dividend Per Share | - | - | 200.000 | 215.000 | 186.284 | Upgrade
|
| Dividend Growth | - | - | -6.98% | 15.42% | 0.46% | Upgrade
|
| Gross Margin | 5.83% | 7.88% | 7.95% | 8.12% | 8.29% | Upgrade
|
| Operating Margin | 2.28% | 2.79% | 2.98% | 2.76% | 2.67% | Upgrade
|
| Profit Margin | 2.92% | 2.44% | 2.68% | 2.47% | 2.41% | Upgrade
|
| Free Cash Flow Margin | 1.22% | -4.15% | 2.61% | 1.17% | 6.53% | Upgrade
|
| EBITDA | 27.79 | 25.26 | 24.09 | 19.36 | 16.62 | Upgrade
|
| EBITDA Margin | 2.92% | 3.03% | 3.21% | 3.08% | 3.02% | Upgrade
|
| D&A For EBITDA | 6.11 | 2.07 | 1.75 | 2.05 | 1.93 | Upgrade
|
| EBIT | 21.68 | 23.19 | 22.33 | 17.31 | 14.69 | Upgrade
|
| EBIT Margin | 2.28% | 2.79% | 2.98% | 2.76% | 2.67% | Upgrade
|
| Effective Tax Rate | 17.76% | 18.20% | 17.62% | 24.93% | 17.66% | Upgrade
|
| Revenue as Reported | 959.96 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.